{"filing":{"accession_number":"0001193125-26-397952","cik":"0001620463","ticker":"LONA","company_name":"LeonaBio, Inc.","form":"8-K","filing_date":"2026-09-22","report_date":"2026-09-18","primary_document":"lona-20260918.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1620463/000119312526397952/lona-20260918.htm"},"events":[{"id":34331,"run_id":31595,"accession_number":"0001193125-26-397952","anchor_item_number":"8.01","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"summary":"LeonaBio disclosed the exercise of Series A Common Warrants issued in a December 2025 private placement, covering 23,031,494 shares with an exercise price of $6.35 per share. The warrants became exercisable on September 18, 2026, and represent a potential $146.2 million capital raise if fully exercised. This is a dilutive equity issuance tied to a prior private placement, material to investors assessing capital structure and shareholder dilution risk.","company_name":"LeonaBio, Inc.","ticker":"LONA","filing_date":"2026-09-22","form":"8-K","submitted_at":null,"items":[{"id":38028,"accession_number":"0001193125-26-397952","item_number":"8.01","item_title":"Other Events.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"LeonaBio disclosed the exercise of Series A Common Warrants issued in a December 2025 private placement, covering 23,031,494 shares with an exercise price of $6.35 per share. The warrants became exercisable on September 18, 2026, and represent a potential $146.2 million capital raise if fully exercised. This is a dilutive equity issuance tied to a prior private placement, material to investors assessing capital structure and shareholder dilution risk.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-22T20:23:53.901677+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":38028,"accession_number":"0001193125-26-397952","item_number":"8.01","item_title":"Other Events.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"LeonaBio disclosed the exercise of Series A Common Warrants issued in a December 2025 private placement, covering 23,031,494 shares with an exercise price of $6.35 per share. The warrants became exercisable on September 18, 2026, and represent a potential $146.2 million capital raise if fully exercised. This is a dilutive equity issuance tied to a prior private placement, material to investors assessing capital structure and shareholder dilution risk.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-22T20:23:53.901677+00:00","company_name":"LeonaBio, Inc.","ticker":"LONA","filing_date":"2026-09-22"}]}